Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Ortoncelli

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Dermatology|December 13, 2024
The need for a shared definition of the atopic dermatitis 'super responder' in the 'treat-to-target' eraLuca Mastorino, Pedro Mendes-Bastos, Simone Ribero, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 22, 2006
Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case studyPaola Savoia, Michela Ortoncelli, Pietro Quaglino, et al.
Expert Opinion on Biological Therapy|August 9, 2023
Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatmentSimone Ribero, Michela Ortoncelli, Luca Mastorino, et al.
International Journal of Dermatology|December 5, 2021
Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?Luca Mastorino, Michela Ortoncelli, Gianluca Avallone, et al.
Dermatology Practical & Conceptual|May 26, 2026
When IL-17 Blockade Backfires: Retropharyngeal Granuloma and Petrous Bone Osteonecrosis in a Patient with PsoriasisLuca Cangialosi, Umberto Santaniello, Michela Ortoncelli, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 14, 2023
Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life ExperienceFederica Gelato, Luca Mastorino, Pietro Quaglino, et al.
Journal of Clinical Medicine|December 9, 2023
Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational StudyFrancois Rosset, Luca Mastorino, Paolo Dapavo, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 26, 2025
IL-17 and IL-23 inhibitors dose spacing in adult psoriatic patients: a real-world pilot studyLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Dermatologic Therapy|December 20, 2019
Efficacy of dupilumab in prurigo nodularis in elderly patientMaria T Giura, Riccardo Viola, Maria T Fierro, et al.
Italian Journal of Dermatology and Venereology|December 17, 2024
Televisits for patients with atopic dermatitis treated with dupilumab: experience from a tertiary care center in Northern ItalyLuca Mastorino, Gitana Scozzari, Simone Ribero, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Dermatology|December 13, 2024
The need for a shared definition of the atopic dermatitis 'super responder' in the 'treat-to-target' eraLuca Mastorino, Pedro Mendes-Bastos, Simone Ribero, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 22, 2006
Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case studyPaola Savoia, Michela Ortoncelli, Pietro Quaglino, et al.
Expert Opinion on Biological Therapy|August 9, 2023
Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatmentSimone Ribero, Michela Ortoncelli, Luca Mastorino, et al.
International Journal of Dermatology|December 5, 2021
Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?Luca Mastorino, Michela Ortoncelli, Gianluca Avallone, et al.
Dermatology Practical & Conceptual|May 26, 2026
When IL-17 Blockade Backfires: Retropharyngeal Granuloma and Petrous Bone Osteonecrosis in a Patient with PsoriasisLuca Cangialosi, Umberto Santaniello, Michela Ortoncelli, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 14, 2023
Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life ExperienceFederica Gelato, Luca Mastorino, Pietro Quaglino, et al.
Journal of Clinical Medicine|December 9, 2023
Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational StudyFrancois Rosset, Luca Mastorino, Paolo Dapavo, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 26, 2025
IL-17 and IL-23 inhibitors dose spacing in adult psoriatic patients: a real-world pilot studyLuca Mastorino, Paolo Dapavo, Michela Ortoncelli, et al.
Dermatologic Therapy|December 20, 2019
Efficacy of dupilumab in prurigo nodularis in elderly patientMaria T Giura, Riccardo Viola, Maria T Fierro, et al.
Italian Journal of Dermatology and Venereology|December 17, 2024
Televisits for patients with atopic dermatitis treated with dupilumab: experience from a tertiary care center in Northern ItalyLuca Mastorino, Gitana Scozzari, Simone Ribero, et al.
Pageof 12